drugset / Trial / NCT00518362

To Compare the Efficacy and Safety of Tripterygium (TW) Versus Valsartan in the Diabetic Nephropathy (DN)

NCT00518362

RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to compare the efficacy and safety of Tripterygium (TW) versus Valsartan (ARB) in the Diabetic Nephropathy (DN).

Timeline

Start
2007-07
Primary completion
2009-09
Completion
2010-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Tripterygium Wilfordii Hook F extract Traditional medicine (herbal / TCM) 60 mg